WELCOME TO The HEALTHCARE REPORT
VonKohn Search Group, Inc
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Exer Labs | October 14, 2021
Exer Labs, an AI-powered digital health company committed to helping healthcare professionals leverage computer vision to modernize their assessments and treatment plans, has launched two new apps, Gait and Physio. Combined with previously launched apps Studio and Range of Motion, Exer now serves the needs of a diverse customer base as they upgrade their abilities to service the entire lifecycle of patients' needs remotely and in-person. Exer's suite of applications is powered by a cu...
SG Blocks, Inc. | October 19, 2020
SG Blocks, Inc., a leader in modular container-based structures and innovator in portable, clinical-grade laboratories for high-capacity testing, and OSANG Healthcare Co., Ltd. (“OSANG” or "OHC"), a South Korea based global manufacturer of medical-grade diagnostic tests and equipment, announced today a Managed Supply Agreement building on their distributorship agreement executed earlier this year, ...
Business Insider | March 06, 2020
Ride-hailing titans Uber and Lyft have each launched a suite of new services aimed at addressing social determinants of health (SDOH), according to Forbes. For context, SDOH refers to health-influencing factors outside clinical settings — such as access to transportation — that drive 80% of health outcomes. And as Uber and Lyft continue proving that their services can help reduce transportation and care costs, we expect to see both brands secure more provider and insurer tie-ups. ......
GNS Healthcare | July 22, 2020
GNS Healthcare (GNS), a leading AI and simulation company, presents results that validate the use of AI to accurately classify tumors based on their immunogenicity and predict response to immune checkpoint inhibitor (ICI) therapy using real-world data. The study showcases the power of causal AI to capture biomarkers and mechanisms, in addition to PD(L)1 and tumor mutation burden (TMB), that are consistent with known immunology. These markers, including CXCL13 upregulation and STK11 mutation, are...
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE